ZKR Orthopedics Announces First Patella LIFT™ Surgeries on the East Coast at Hospital for Special Surgery in Enrollment of FDA PELICAN Trial
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) — ZKR Orthopedics announced today that the first Patella LIFT™ procedures on the East Coast were successfully performed as part of the PELICAN TRIAL, at the renowned Hospital for Special Surgery (HSS) in New York City. Esteemed orthopedic surgeons Dr. Sabrina Strickland and Dr. Andreas Gomoll led the groundbreaking initiative, completing four Patella LIFT™ implant surgeries in patients suffering from advanced patellofemoral joint disease.
The outpatient procedures were performed as part of an ongoing FDA IDE clinical trial (NCT 06423300), which is evaluating the safety and effectiveness of the Patella LIFT™ implant. The device has demonstrated promising results in an earlier clinical trial in Europe, providing participants with significant improvement in pain and function. To date, a total of 16 Patella LIFT™ procedures have been performed in the United States, marking steady progress in the study of this innovative treatment.
